5 Steps to Choose an Addiction Marketing Consultant

Six questions do most of the sorting.

1. Describe a campaign you paused or rewrote after the June 2025 Evoke Wellness settlement, and what changed in ad copy, landing pages, or call-center scripts ¹⁴. A specialist will name specific edits — dropping impersonation-adjacent language, removing competitor brand terms from search ads, adding call disclosures. A generalist will speak in principles.
2. Walk through how your team handles a Google Business Profile impersonation complaint, including escalation to the platform and to counsel ¹⁵.
3. What does your intake for a new treatment client look like when the site already runs Meta Pixel, Google Analytics, and a session-replay tool ⁵?
4. How do you document substantiation for a phrase like “evidence-based” or “industry-leading outcomes” before it ships ⁸?
5. What is your written policy on soliciting alumni reviews, and how do you handle incentives or draft language provided to the reviewer ⁶?
6. How is your fee structured, and what would you change if we asked you to price per admission ¹²? Answers that treat the last question as negotiable are a disqualifier, not a starting point.

Directory hygiene is a low-glamour discipline that reveals whether a consultant actually operates in the space. A 2024 cross-sectional analysis of ten national and state-level SUD treatment search tools found exact accuracy of listed facility information ranging from 9.1% to 76.0%, with a mean of 56.0%; functional accuracy averaged 82.8% ¹⁶. The study looked at directory records rather than every facility in the country, and results will vary by region and level of care, but the baseline is instructive: roughly half of exact facility details in surveyed directories were wrong.

A consultant who cannot describe how they audit SAMHSA’s treatment locator, state directories, insurance-directory feeds, and major review platforms — on a defined cadence, with a written correction workflow — is not doing the specialization work. Ask for a sample audit from a comparable client, redacted as needed, and confirm who owns corrections when a payer directory lists the wrong level of care or an outdated intake line.

The FTC’s Health Products Compliance Guidance sets a specific bar: advertisers must possess adequate substantiation for objective claims before an ad runs, and health-related claims generally require competent and reliable scientific evidence ⁸. That standard applies to phrases treatment centers use every day — “evidence-based,” “proven outcomes,” “industry-leading success rates,” “most insurance accepted,” “same-day admissions.” Each is an objective claim. Each requires documentation before publication, not after a regulator asks.

A working consultant should be able to produce a claim log for any active campaign: the exact phrase, where it appears, the underlying evidence, and who approved it. Ask to see one. The FTC also treats implied claims as separately actionable, so disclaimers below the fold do not cure a headline that overstates typical results ⁸. If the consultant’s answer to “how do you substantiate this?” is a case study from a different facility or a testimonial, that is not substantiation — it is illustration, and the two are not interchangeable under the guidance.

The June 2025 Evoke Wellness settlement gave the addiction-treatment sector a specific playbook for what deceptive marketing looks like in an enforcement file. The FTC’s order:

• Banned misleading representations about SUD-treatment services;
• Prohibited impersonating other businesses;
• Restricted use of rivals’ names in search-engine ads; and
• Required a compliance program for call centers ¹⁴.

A consultant should be able to walk through each of those provisions and describe how their own workflow would have avoided the conduct.

The dollar exposure adjacent to healthcare marketing has escalated in parallel. Evoke Wellness paid $1.9 million to resolve the FTC’s claims ¹⁴. In August 2025, the FTC announced a combined $145 million settlement with Assurance IQ and MediaAlpha over deceptive health-insurance lead generation and telemarketing practices ¹⁰. And in March 2025, DOJ announced a 41-month federal prison sentence for a defendant who paid nearly $2.9 million in kickbacks to patient recruiters in an addiction-treatment case ¹³. A consultant who treats competitor-name bidding, brand impersonation on Google Business Profile, or unmonitored outsourced call centers as growth tactics is proposing exposure the facility, not the vendor, will absorb.

Three regimes touch nearly every marketing workflow a treatment center runs, and they should be discussed together because they overlap in practice. Part 2 restricts use and disclosure of records maintained by a Part 2 program and requires disclosures to be limited to information necessary for the permitted purpose ⁴. Any dataset that identifies a person as seeking or receiving SUD treatment can fall inside that perimeter — intake form submissions, call recordings, CRM notes, remarketing audience membership. HHS confirmed in the 2024 final rule that compliance is required by February 16, 2026 ¹, and the model notices HHS published require covered entities to describe Part 2 protections in their notices of privacy practices starting on that date ³.

HIPAA sits alongside. HHS defines marketing as a communication encouraging recipients to purchase or use a product or service and generally requires authorization for a covered entity’s use or disclosure of PHI for marketing, subject to exceptions ². That definition governs email lists, lookalike audiences, and any campaign built from patient data. And OCR’s 2024 bulletin on online tracking made clear that pixels, cookies, session replay, and fingerprinting can collect information about users’ interactions with websites or apps, and that an impermissible disclosure of PHI to a tracking vendor may trigger breach-notification obligations ⁵. Ask the consultant to describe, in one sitting, how a form submission on a detox landing page moves from browser to CRM to ad platform — and where each of these three regimes attaches along the path. Silence at any step is the finding.

The deliverable a serious consultant should produce is a written data-flow diagram covering every intake surface: web forms, click-to-call, chat widgets, tracked phone numbers, SMS follow-up, and any pixel or tag that fires on a conversion event. The diagram should identify:

• Each vendor in the path;
• Whether a business associate agreement is in place;
• What data fields are transmitted; and
• Whether the transmission is stripped of identifiers before it leaves the facility’s environment.

OCR treats tracking-vendor disclosures as evaluable in context, so generic reassurance that “we use standard analytics” is not a response ⁵.

Notice alignment is the second deliverable. Website privacy policies, intake-form disclosures, and the facility’s notice of privacy practices must describe what the marketing stack actually does — including SUD-specific protections that must appear in notices beginning February 16, 2026 ³. The consultant implements content and technical changes; the facility’s privacy officer and counsel own the final language. A vendor who blurs that line is a vendor to walk away from.

Ask the consultant to walk through, request by request, how alumni and family reviews are solicited. The FTC rule prohibits businesses from creating, selling, buying, or disseminating fake or false reviews and testimonials when they knew or should have known the content was deceptive, and reaches AI-generated testimonials, purchased reviews, and compensation tied to sentiment ⁷. A workflow that offers a gift card only for five-star reviews, drafts language for the reviewer to paste, or uses generative tools to fabricate alumni voices is a workflow the facility cannot sign off on.

Three artifacts should be on the table:

• The outreach template sent to former patients or families;
• The moderation policy for negative reviews on the facility’s own properties; and
• The written stance on AI-assisted drafting.

The rule does not bar genuine solicitation of honest feedback, and it does not prohibit negative reviews from appearing ⁶. It does bar suppression tactics and undisclosed insider reviews written by employees, executives, or their immediate relatives ⁷. A consultant who cannot produce those three documents is running the workstream informally, which is where the enforcement risk lives.

Produced recovery stories carry a second layer of risk. The FTC warns that unrepresentative testimonials may mislead unless accompanied by information about what consumers generally can expect, and that material connections between the endorser and the advertiser must be disclosed ¹⁷. A former patient who received a discounted stay, a free retreat, or ongoing alumni benefits in exchange for a video is a material connection. So is a clinician endorser whose relationship to the facility is not obvious to a viewer.

Two questions cut through most pitches. First: how does the consultant document that a recovery story reflects a typical outcome, and what disclosure appears when it does not? Second: what is the written consent and Part 2 authorization process before a former patient’s image, voice, or story enters a paid campaign? A vague answer to either is a reason to keep looking.

EKRA prohibits knowingly and willfully soliciting, receiving, paying, or offering remuneration to induce referrals or use of services at a recovery home, clinical treatment facility, or laboratory, with penalties reaching $200,000 and ten years’ imprisonment per occurrence ¹². The statute reaches all payers, not just federal programs, which is what distinguishes it from the older Anti-Kickback Statute framework many agencies still cite as their comfort zone. A per-admission fee, a bounty on qualified calls, or a revenue-share on billed services all sit inside the conduct the statute describes.

The exceptions are real but narrow. EKRA contains a safe harbor for certain bona fide employment or contractual arrangements whose compensation is not determined by the number of referrals, tests, or amounts billed ¹². Fixed monthly retainers, hourly consulting, and deliverable-based fees generally fit that shape; performance bonuses tied to admissions volume generally do not. The evaluation is fact-specific and belongs to counsel. A consultant who cannot articulate the distinction, or who offers to “structure around” EKRA without involving the facility’s attorney, is not a vendor to negotiate with. The DOJ’s March 2025 sentencing of a defendant to 41 months in federal prison for paying nearly $2.9 million in kickbacks to patient recruiters is the reminder that enforcement in this corner of the industry is not theoretical ¹³.

Lead-generation architecture is where compensation risk quietly compounds. The FTC has stated that lead generators should tell the truth about their identity and affiliations, how consumer information will be used, and what consumers will receive for submitting information ¹¹. When a consultant runs landing pages under generic wellness brands, routes calls through third-party centers, or resells form fills to other facilities, the facility whose name appears on the intake still absorbs the exposure.

Two contract questions surface most of the risk:

• Who owns the landing page domain, phone numbers, and lead data — the consultant, a subcontractor, or the facility?
• What audit rights does the facility have over call recordings, disclosure scripts, and Telemarketing Sales Rule compliance for any outbound follow-up, including prerecorded messages that generally require prior signed written consent ⁹?

A consultant unwilling to grant those rights is proposing a black box the facility cannot defend.